← Back
$LAB All transactions

STANDARD BIOTOOLS INC.

▲ BUY
6 / 10

Conviction

$ Value

$129K

Shares

100,000

Price

$1

Filed

Sep 11

Why this score? (6/10)
  • Open market buy (+3)
  • Director (+1)
  • 10%+ owner (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

Casdin Partners Master Fund, L.P.

Title

CIK

0001534265

Roles

Director 10% Owner

Transaction Details

Transaction Date

2025-09-09

Code

P

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

60,875,000

Footnotes

The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $1.2889 to $1.2895. The Reporting Persons undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote. | The securities are owned directly by Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC ("Casdin"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC (the "GP"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin and the GP. | The securities are owned directly by Eli Casdin. | The securities are owned directly by Casdin Private Growth Equity Fund II, L.P. (the "Equity Fund II") and may be deemed to be indirectly beneficially owned by (i) Casdin, the investment adviser to the Equity Fund II, and (ii) Eli Casdin, the managing member of Casdin. | The securities are owned directly by Casdin Private Growth Equity Fund, L.P. (the "Equity Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin, the investment adviser to the Equity Fund, and (ii) Eli Casdin, the managing member of Casdin.

Filing Info

Accession No.

0000919574-25-005636

Form Type

4

Issuer CIK

0001162194

Casdin Partners Master Fund, L.P.'s History

Date Ticker Type Value
2025-11-12 LAB $446K
2025-11-11 LAB $359K
2025-11-10 LAB $322K
2025-11-07 LAB $253K
2025-10-15 BLFS $21.4M
2025-09-09 LAB $129K
2025-09-04 LAB $319K
2025-09-03 LAB $316K
2025-08-26 LAB $158K
2025-08-25 LAB $248K

Other Insiders at LAB (90d)

Insider Bought Sold Last
Egholm Michael
President & CEO
2026-04-06
Mackay Sean
SVP & Chief Business Officer
2026-03-20
Kim Hanjoon Alex
Chief Financial Officer
2026-04-06